Convergence Investment Partners, LLC Amneal Pharmaceuticals, Inc. Transaction History
Convergence Investment Partners, LLC
- $431 Million
- Q4 2024
A detailed history of Convergence Investment Partners, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 208,009 shares of AMRX stock, worth $1.74 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
208,009
Previous 166,848
24.67%
Holding current value
$1.74 Million
Previous $1.39 Million
18.66%
% of portfolio
0.38%
Previous 0.38%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$124 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.5 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.8 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$75.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...